Status
A multinational clinical project (OligoG-pivotal-CF) to test the orphan drug OligoG CF-5/20 in a pivotal phase 2b clinical trial for the treatment of cystic fibrosis.
A multinational clinical project (OligoG-pivotal-CF) to test the orphan drug OligoG CF-5/20 in a pivotal phase 2b clinical trial for the treatment of cystic fibrosis.
The project status will be updated periodically to reflect the progress of the clinical study. Patient enrollment is due to start H1 – 2020.
The clinical trial will include 120 CF patients from 45 European sites in coordination with the European Clinical Trial Network.
The clinical trial will include 120 CF patients from 45 European sites in coordination with the European Clinical Trial Network.
Partners
European sites